findmyKOL

Michael McDermott, MD

Basic profile

University of Colorado Hospital

ORCIDNPI
RegionAurora, CO · WestSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Michael McDermott is an Endocrinology/Metabolic physician affiliated with University of Colorado Hospital. OpenAlex indexes 117 publications with 3,096 citations (h-index 27); ClinicalTrials.gov lists 4 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
117publications

Distinct works indexed by OpenAlex, matched via ORCID.

3,096citations

Total citations across indexed works.

27h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials
5companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

12605 E 16th Ave
Aurora, CO 800452545

Telephone

720-848-0000

Registry record last updated 3 Jan 2011.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    62%
    GLP-1 receptor agonist22.4%
    Ozempic42%Mounjaro31%Trulicity24%Rybelsus2%
    Part D<11 patients
    Insulin Analog22.1%
    Lantus Solostar22%Humalog Kwikpen U-10016%Tresiba Flextouch U-10012%Novolog Flexpen8%Tresiba Flextouch U-2008%Humalog6%Basaglar Kwikpen U-1005%Toujeo Max Solostar5%Novolog5%Toujeo Solostar3%Fiasp Flextouch3%Insulin Lispro Kwikpen U-1003%Lantus3%Fiasp2%
    Part D<11 patients

    + 5 more classes in this area

  • Cardiovascular

    18.5%
    Statin7.7%
    Atorvastatin Calcium69%Rosuvastatin Calcium15%Simvastatin9%Pravastatin Sodium7%
    Part D<11 patients
    Angiotensin receptor blocker (ARB)2.9%
    Losartan Potassium74%Valsartan14%Olmesartan Medoxomil12%
    Part D<11 patients

    + 7 more classes in this area

  • Hormonal (systemic)

    13.9%
    l-Thyroxine10.4%
    Levothyroxine Sodium74%Synthroid26%
    Part D73 patients
    Parathyroid Hormone-Related Peptide Analog0.8%
    Tymlos100%
    Part D<11 patients

    + 5 more classes in this area

Where care is delivered (Part B)84.9% facility · 15.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”